Biomarker discovery organization accelerating drug development through rapid, large-scale small molecule biomarker profiling.
Sapient has raised $9.2M in total funding. The most recent round was Grant. The last funding was announced in July 2022.
Sapient's investors include Bill & Melinda Gates Foundation.
Sapient is headquartered in San Diego, United States.
Biomarker discovery organization accelerating drug development through rapid, large-scale small molecule biomarker profiling.
Sapient is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sapient — Funding & Investors." VCBacked, July 11, 2022, https://www.vcbacked.co/company/sapient. Accessed August 14, 2026.
VCBacked. (2022). Sapient — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/sapient
{{cite web |title=Sapient — Funding & Investors |url=https://www.vcbacked.co/company/sapient |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated